17-octadecynoic acid has been researched along with Injury, Myocardial Reperfusion in 2 studies
octadec-17-ynoic acid : An acetylenic fatty acid that is octadecanoi acid (stearic acid) which has been doubly dehydrogenated at positions 17 and 18 to give the corresponding alkynoic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, X | 1 |
| Wan, J | 1 |
| Yang, J | 1 |
| Cheng, H | 1 |
| Li, Y | 1 |
| Ao, Y | 1 |
| Peng, R | 1 |
| Nithipatikom, K | 1 |
| Gross, ER | 1 |
| Endsley, MP | 1 |
| Moore, JM | 1 |
| Isbell, MA | 1 |
| Falck, JR | 1 |
| Campbell, WB | 1 |
| Gross, GJ | 1 |
2 other studies available for 17-octadecynoic acid and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion.
Topics: Amides; Amidines; Animals; Apoptosis; Caspase 3; Cytochrome P-450 CYP4A; Enzyme Activation; Fatty Ac | 2008 |
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; | 2004 |